Dr Peter Wilmshurst is a consultant cardiologist. He is a leader in his field, and also a whistleblower, drawing attention to that which he believes to be wrong. He was presented with the HealthWatch Award 2003. Peter Wilmshurst has clashed with universities, editors, the medical establishment, and – perhaps inevitably – with the pharmaceutical industry. It is this last encounter that has taken him to court and that has made explicit and very public the relevance of the UK’s libel laws to scientific research.
PAGES
67 – 71
DOI
All content is freely available without charge to users or their institutions. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles in this journal without asking prior permission of the publisher or the author. Articles published in the journal are distributed under a http://creativecommons.org/licenses/by/4.0/.
Issues
Also in this issue:
-
Do AIs have politics? Thinking about ChatGPT through the work of Langdon Winner
-
Creating value through service innovation: an effectual design thinking framework
-
Health and medical researchers are willing to trade their results for journal impact factors: results from a discrete choice experiment
-
The death and resurrection of manuscript submission systems
-
Ryan Jenkins, David Černý and Tomáš Hříbek (eds) Autonomous Vehicle Ethics: The Trolley Problem and Beyond
The effects of the English libel laws on medicine and research – a personal view
Proposition